{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T19:04:11Z","timestamp":1788116651062,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.07.096","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:39:10Z","timestamp":1467765550000},"page":"627-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ivabradine and the anti-inflammatory effects in patients with ischemic heart disease"],"prefix":"10.1016","volume":"221","author":[{"given":"Alberto","family":"Dominguez-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Abreu-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.07.096_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.04.001","article-title":"Ivabradine in chronic stable angina: effects by and beyond heart rate reduction","volume":"215","author":"Camici","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2174\/138945009789577963","article-title":"Inflammatory systemic biomarkers in setting acute coronary syndromes\u2014effects of the diurnal variation","volume":"10","author":"Dominguez-Rodriguez","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ijcard.2016.07.096_bb0015","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy","volume":"31","author":"Morrow","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0025","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.19.8.1979","article-title":"Heart rate variability and progression of coronary atherosclerosis","volume":"19","author":"Hikuri","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0030","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality in the Framingham study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ehj.2003.12.003","article-title":"Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease","volume":"25","author":"Sajadich","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2011.07.067","article-title":"C-reactive protein and endothelial dysfunction: gazing at the coronaries","volume":"152","author":"Tousoulis","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2004.05.019","article-title":"Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein","volume":"98","author":"Koenig","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4330\/wjc.v3.i4.101","article-title":"Increased heart rate and atherosclerosis: potential implications of ivabradine therapy","volume":"26","author":"Dominguez-Rodriguez","year":"2011","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0055","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","article-title":"Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E deficient mice","volume":"117","author":"Custodis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.096_bb0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2012.04.076","article-title":"Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study","volume":"158","author":"Dominguez-Rodriguez","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.096_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2010.03.002","article-title":"Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice","volume":"212","author":"Baumh\u00e4kel","year":"2010","journal-title":"Atherosclerosis"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316314498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316314498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:20:18Z","timestamp":1536589218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316314498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":13,"alternative-id":["S0167527316314498"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.096","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivabradine and the anti-inflammatory effects in patients with ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}